Mutations and thrombosis in essential thrombocythemia
Main Authors: | Paola Guglielmelli, Naseema Gangat, Giacomo Coltro, Terra L. Lasho, Giuseppe Gaetano Loscocco, Christy M. Finke, Erika Morsia, Benedetta Sordi, Natasha Szuber, Curtis A. Hanson, Animesh Pardanani, Alessandro M. Vannucchi, Ayalew Tefferi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-021-00470-y |
Similar Items
-
Venetoclax-based chemotherapy in acute and chronic myeloid neoplasms: literature survey and practice points
by: Naseema Gangat, et al.
Published: (2020-11-01) -
CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
by: Evandro D. Bezerra, et al.
Published: (2021-03-01) -
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
by: Hassan Awada, et al.
Published: (2020-06-01) -
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
by: Giuseppe G. Loscocco, et al.
Published: (2021-08-01) -
Essential Thrombocythemia Complicated by Occlusive Thrombosis of the Abdominal Aorta
by: Jamie Geringer, et al.
Published: (2019-01-01)